Table 2.
Adjusted odds ratios* and 95% CIs for the association of adverse outcomes with OGTT values and GDM
Fasting glucose |
1-h glucose |
2-h glucose |
GDM | ||||
---|---|---|---|---|---|---|---|
Continuous, per 1 SD from the mean | <92 vs. ≥92 mg/dl | Continuous, per 1 SD from the mean | <180 vs. ≥180 mg/dl | Continuous, per 1 SD from the mean | <153 vs. ≥153 mg/dl | ||
LGA | 1.32 (1.23–1.42) | 2.04 (1.70–2.44) | 1.31 (1.22–1.42) | 1.52 (1.19–1.94) | 1.26 (1.17–1.36) | 1.36 (0.96–1.95) | 1.86 (1.57–2.20) |
Primary cesarean section | 1.07 (1.01–1.14) | 1.20 (1.01–1.43) | 1.13 (1.06–1.21) | 1.02 (0.81–1.29) | 1.20 (1.13–1.28) | 1.41 (1.04–1.92) | 1.18 (1.01–1.37) |
Preterm delivery | 1.12 (1.03–1.21) | 1.35 (1.07–1.69) | 1.23 (1.13–1.34) | 1.57 (1.19–2.08) | 1.19 (1.10–1.30) | 1.84 (1.31–2.60) | 1.64 (1.35–2.00) |
Shoulder dystocia/birth injury | 1.09 (0.98–1.21) | 1.51 (1.14–2.00) | 1.17 (1.05–1.31) | 1.55 (1.08–2.22) | 1.23 (1.11–1.38) | 1.25 (0.73–2.14) | 1.50 (1.17–1.94) |
Gestational hypertension | 1.14 (1.05–1.23) | 1.41 (1.14–1.74) | 1.31 (1.20–1.42) | 1.70 (1.30–2.23) | 1.27 (1.16–1.38) | 1.94 (1.35–2.80) | 1.51 (1.24–1.83) |
Hyperbilirubinemia | 0.98 (0.92–1.05) | 0.99 (0.82–1.18) | 1.13 (1.06–1.21) | 1.14 (0.91–1.43) | 1.07 (1.00–1.14) | 1.27 (0.94–1.71) | 1.12 (0.96–1.30) |
*Odds ratios for OGTT measures are for an increase in glucose level of 1 SD (7.99 mg/dl for FPG, 30.84 mg/dl for 1-h glucose, and 23.08 mg/dl for 2-h glucose) and are adjusted for maternal age, race/ethnicity, parity, prepregnancy BMI, gestational weight gain, infant sex, and gestational age at OGTT.